featured
AI for Diagnosis and Gleason Grading of Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge
Nat. Med. 2022 Jan 13;[EPub Ahead of Print], W Bulten, K Kartasalo, PC Chen, P Ström, H Pinckaers, K Nagpal, Y Cai, DF Steiner, H van Boven, R Vink, C Hulsbergen-van de Kaa, J van der Laak, MB Amin, AJ Evans, T van der Kwast, R Allan, PA Humphrey, H Grönberg, H Samaratunga, B Delahunt, T Tsuzuki, T Häkkinen, L Egevad, M Demkin, S Dane, F Tan, M Valkonen, GS Corrado, L Peng, CH Mermel, P Ruusuvuori, G Litjens, M EklundFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.